Talphera Inc. (TLPH)

[murocman]

In reading some other boards/sites(YMB...much as I hate to & SA), it seems there is some doubt as to whether or not there would be a fast/significant uptake because current IV delivery is so cheap and already the SOC. The debate seems to center on the fact that the benefits of the ACRX solution are mostly for nurses (the deliverers) and patients (longer efficacy due to timed absorption due to delivery method), so unless Doctors and more importantly, cost reimbursement entities get behind this, it might be tough sledding.

All that said, this definitely seems to hold the promise of being a much better mousetrap and one would think it would be a no brainer. I have a small position here and may add on weakness heading into the remainder of the Ph III data.

GLTU,

Murocman